[Springer] Polycythemia due to SGLT-2 inhibitors: who is at risk? |
|
This post will be closed automatically in 2026-06-08 01:19
Reward10points
|
post
reply
points
1101
20
Nanoencapsulation and delivery of bioactive ingredients using zein nanocarriers: approaches, characterization, applications, and perspectives
10
Understanding and Managing the Hazards and Opportunities of Lunar Regolith in Greenhouse Agriculture
10
Polycythemia due to SGLT-2 inhibitors: who is at risk?
10
Exploring the role of resistin as a biomarker of early renal changes in pediatric type 1 diabetes mellitus
20
The Use of Biologics for Thyroid Eye Disease
